Unified Patent Court (UPC) analytics are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Cms Cameron Mckenna Nabarro Olswang opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Cms Cameron Mckenna Nabarro Olswang

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3522732Methods And Systems For Generating A Sterilized Human Milk ProductIMBJan 23, 2025STRAWMAN
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024CMS CAMERON MCKENNA NABARRO OLSWANG
EP39273375-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating DepressionGH RESEARCHNov 13, 2024STRAWMAN
EP2849802Treatment Of Amd Using Aav Sflt-1AVALANCHE AUSTRALIASep 19, 2024STRAWMAN
EP3542790Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024CMS CAMERON MCKENNA NABARRO OLSWANG
EP3695012Inhibition Of Hsd17B13 In The Treatment Of Liver Disease In Patients Expressing The Pnpla3 I148M VariationREGENERON PHARMACEUTICALSDec 8, 2023STRAWMAN
EP3307872Methods And Compositions For Efficient Delivery Of Nucleic Acids And Rna-Based AntimicrobialsNORTH CAROLINA STATE UNIVERSITYOct 30, 2023SNIPR BIOME APS
EP3199174Uses Of Neuregulin In Preventing, Treating Or Delaying Ventricular Arrhythmia, And Composition ThereofZENSUN SHANGHAI SCIENCE AND TECHNOLOGYJan 13, 2023STRAWMAN
EP3848454Live Cell Constructs For Production Of Cultured Milk Product And Methods Using The SameBIOMILQNov 9, 2022STRAWMAN
EP3636778Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)UNIVERSITY OF ROCHESTEROct 12, 2022CMS CAMERON MCKENNA NABARRO OLSWANG